lized in an attempt to characterize the tissue damage 
similar to those seen in transferase-deficient humans may be seen in galactose loaded rats, the model still does not mimic the human who develops Galactose-1-phosphate uridylyl transferase (E.C.
symptoms despite a diet highly restricted in galac-2.7.7.12 or GALT) is the second enzyme in the Leloir tose. pathway. GALT catalyzes the conversion of galacTo facilitate study of the pathogenesis of GALT tose-1-phosphate and UDP-glucose to glucose-1-deficiency, we have made mice deficient in GALT phosphate and UDP-galactose. Classical galacactivity using gene targeting and embryo transfer tosemia, which is estimated to occur in about 1 of techniques. Mice with GALT deficiency (GALT 50,000 births, is caused by the complete or nearknockout) accumulate large amounts of galactose complete deficiency of GALT (1) . The symptoms of and galactose-1-phosphate in their tissues, but do galactosemia are typically classified into two phases.
not show evidence of the acute toxicity syndrome The first, the diet-dependent phase, occurs in newduring the suckling period. Therefore, these animals borns, who, when exposed to dietary galactose in are viable and allow detailed study of galactose memammalian milk, develop an acute toxicity picture tabolism and possible mechanisms for long-term toxwith liver disease, renal tubular dysfunction, and icity. Escherichia coli sepsis. The second phase has been characterized as diet independent, since patients who have never been exposed to large amounts of METHODS dietary galactose may still develop the symptoms, and involves brain abnormalities, including an Construction of an mGALT targeting vector. Using a full-length mouse liver GALT cDNA (4), a l ataxia syndrome, speech dyspraxia, mental retardation, and premature ovarian failure in females (2) .
phage encompassing the complete coding region of the mGALT gene was isolated from a 129 genomic The pathophysiology for these problems remains unclear nearly 60 years after the first description of library obtained from T. Doetschman, Department of Molecular Genetics, University of Cincinnati College the disease (3).
of Medicine. Sequence analysis of this phage and of pearance of a 3.3-kb band was evidence of an appropriate targeting event, seen in 8 of the 25 lines. a phage isolated from a Balb C genomic library (Clontech) showed structural similarity to the human Four of the targeting lines were selected for injection into C57B16 blastocysts and subsequently im-GALT gene previously described (4) . Comparison of planted into pseudopregnant CF1 females. Mice chithe phage from the two mouse species showed only meric for the chinchilla coat color were produced minor intronic sequence changes through the coding from three of the four lines and germline transmisregion.
sion of the coat color marker was demonstrated for A 7-kb EcoRI fragment from the 129 library was two lines. The progeny of these mice were used for subcloned into pBluescript and modified as follows all subsequent experiments. to create a targeting vector. A 700-bp BglII fragment Initial breeding from germline chimeras produced was excised. This fragment includes exon 6, which two male/female pairs heterozygous for the targeting codes for the catalytic site, as well as exons 7 and 8.
marker. Breeding of these pairs yielded litters of The BglII fragment was replaced by a 6-kb HPRT normal size, and none of the mice showed a phenominigene cassette bounded by BamHI (5). A 2-kb type of jaundice or failure to thrive. Tail DNA from HSV-TK cassette was cloned into the KpnI site of these litters was digested with EcoRI and probed pBluescript upstream from the 5 boundary of the with the EcoRI-XbaI genomic probe. In DNA from targeting sequence and the resulting vector was linhomozygous animals, the 7-kb band from the endogearized with NotI. The final vector contained exons enous gene was absent, and two new bands (3.8 and 3-5 in the region of short homology and exons 9-9.2 kb) corresponding to the targeted locus were 11 as well as a long 3 flanking region in the region present. of long homology. Known sequence and restriction sites were reserved outside the targeting construct Biochemical studies. Litters were sacrificed by for determination of appropriate integration events decapitation after brief CO 2 narcosis, and tissues in ES cells.
were harvested and quick frozen for study of GALT activity or galactose-1-phosphate. A separate set of Detection of targeted allele. E14 embryonic stem animals was sacrificed and blood collected into a hepcells were grown on mitomycin C-treated murine arinized syringe by cardiac puncture. Plasma was embryonic fibroblasts (MEFs) in the presence of ESseparated for galactose determination, the erythro-GRO (Gibco). Ten million cells were trypsinized and cytes were washed twice with normal saline and electroporated with the linearized vector and then then analyzed for galactose-1-phosphate content. seeded onto MEFs (6). After 24 h recovery, HAT and GALT activity was determined by radioenzymatic gancyclovir were added to the medium, yielding conversion of [ UDP galactose (7). Galactose-1-phosphate was dewere picked and analyzed by PCR, using an upper termined enzymatically in both liver homogenates primer (ACTCCCCTCCGCCAGCCTAT) correspondand erythrocyte hemolysates (8). Galactose content ing to IVS A of the upstream mGALT sequence and and galactitol content of plasma were determined by a lower primer (CCACCGTGTGTTAGAAAAGT) capillary GC with FID detection (9). Protein content complementary to the HPRT minigene cassette. For of liver homogenates was determined spectrophoto-PCR, DNA was isolated from a single 15-mm well metrically (Bio-Rad). in PCR lysis buffer (50 mM KCl, 10 mM TrisrHCl, pH 8.3, 2.5 mM MgCl 2 , 1 mg/ml gelatin, 0.45% Triton RESULTS X-100, 0.45% Tween 20), digested with proteinase K (200 mg/ml final, 56ЊC 1 2 h), then amplified in a GALT Gene Targeting Perkin-Elmer Cetus DNA thermal cycler (30 cycles, 1 min at 94ЊC, 1 min at 50ЊC, 2 min at 72ЊC). ProdTo disrupt the mouse GALT gene by homologous ucts were analyzed on a 1% agarose gel. The presrecombination, a targeting vector was constructed ence of a 1.35-kb band was considered evidence of in which exons 6, 7, and 8 were replaced by a 6-appropriate targeting. Of the tested colonies, 50 kb HPRT minigene construct (5) which served as a were positive by PCR, and 25 of these were expanded marker for positive selection in E14 cells (Fig. 1 ). and further evaluated by Southern analysis, using Exon 6 of both mouse and human GALT genes (5) an XbaI digest, and probed with a 4-kb EcoRI-XbaI encodes the His-Pro-His sequence previously demonstrated to be the catalytic site (10). For additional genomic probe, encompassing exons 3-11. The ap- negative selection, a 2-kb HSV-TK cassette was tained at 14 days of age showed transmission of the interrupted GALT gene in the expected ratios, with cloned into a KpnI site at the 5 end of the mGALT genomic clone. We electroporated E14 cells and subno bias against homozygous pups (Table 1) . jected them to positive/negative selection using ganBiochemical Phenotype cyclovir and HAT. After 120 colonies were screened by polymerase chain reaction and confirmed by Litters from heterozygous matings were sacrificed Southern blotting, eight cell lines were obtained in at 7 days of age. Liver and kidneys were removed, which both PCR and Southern analysis yielded posiflash frozen, and stored at 080ЊC for future analysis. tive results. Three of these lines were injected into GALT activity was analyzed by a standard radioenblastocysts of C57BL/6, and chimeric progeny, typed zymatic conversion of [ 14 C]-galactose-1-phosphate to by coat color, were obtained from all three. Chimeric [ 14 C]UDP galactose and normalized to protein conoffspring were bred to CF1 mates, yielding chinchilla tent. Enzyme levels were then compared to Southern coat color offspring from two of the three lines. Southern blotting of DNA from tail snips of these observed. Examination of DNA from tail snips ob- analysis of tail snip DNA. Animals homozygous for and heterozygous animals. Galactose in the plasma (Table 2) was also substantially elevated, although the interrupted GALT allele had enzyme activity in the undetectable range, while heterozygous animals there was no depression of plasma glucose. A trace of galactitol was found in the GALT knockout aniexhibited activities which were approximately half those of the normal littermates (Fig. 2) . Radioenzymals, but not in the normal controls. These data indicate that suckling mice that have no detectable matic assay results in GALT knockout mice cannot be distinguished from background and are compara-GALT activity accumulate large amounts of galactose as well as galactose-1-phosphate but still appear ble to tissue levels from patients homozygous for the Q188R mutation. Therefore the interrupted GALT healthy. allele is a null allele.
Galactose-1-phosphate levels in the liver homogeFertility in GALT Knockout Females nates (Fig. 2 ) and in erythrocytes (Table 2) collected from separate litters were assayed and found to be Once viability to the stage of weaning was demonsubstantially elevated over levels found in control strated, homozygous female mice were bred to normal males. These young females, who were consum- GALT activity appear to have normal fertility, at sented as mean { SD (n). ND, below limit of dection (galactose, galactitol õ 20 nmol/liter).
least during young adulthood. is not feasible. Most of the evidence for toxicity of galactose-1-phosphate has been obtained from paNote. Litters produced by 5 young (8 weeks) gal0/gal0 females tients with abnormalities in galactose metabolism.
(F1 or F2) bred to normal males. ''Days'' refers to the number of days from the introduction of the male to birth of the litter. Pups
However, patients with partial GALT deficiency, were counted at 2 days of age and all survived to weaning.
who have no acute toxicity symptoms, may accumulate galactose-1-phosphate in their erythrocytes at levels comparable to those found in our mice. Levels Pathological Examination of Tissues from GALT found in symptomatic newborns with classical galacKnockout Mice tosemia may overlap the range found in humans with partial GALT deficiency (11) and in GALT Livers from 7-day-old pups were obtained after knockout mice. sacrifice and promptly fixed in zinc-buffered formaGalactitol, on the other hand, may assume a more lin. Hematoxylin-eosin staining of paraffin-embedimportant role in future studies of pathophysiology. ded sections was performed. GALT knockout mice When present as the ''sole'' offending metabolite, as had no histologic features that distinguished them in galactokinase deficiency, it does not produce liver from heterozygous or normal littermates. and kidney pathology. However, it can be found in livers (12), plasma (13), and urine (13) of patients DISCUSSION with classical galactosemia, and levels have been found to increase in response to ingestion of free Complete GALT deficiency in humans, although compatible with embryonic survival, is a morbid congalactose (9). The combined accumulation of galactitol and galactose-1-phosphate is not observed in dition. Rapid development of liver, kidney, intestinal, and central nervous system toxicity occurs in these mice, which is not surprising, since mice, in contrast to rats, express very low levels of endogenewborns exposed to the large amounts of galactose present in human or humanized cow milk formulas.
nous aldose reductase, making them highly resistant to galactose-induced cataracts (14,15). This resisThe finding that a GALT knockout mouse survives the suckling period with no evidence of toxicity was tance can be overcome in transgenic mice expressing aldose reductase activity. The expression of such a surprising, especially when correlated with biochemical evidence of galactose and galactose-1-phosphate transgene in GALT knockout mice might produce an animal with dual accumulation of galactitol and accumulation at levels comparable to those in humans with classical galactosemia.
galactose-1-phosphate, facilitating further study of the hypothesis that the pathophysiology of GALT The galactose-1-phosphate levels are of particular interest. Galactose-1-phosphate accumulates in padeficiency can be linked to accumulation of both substrates. tients with GALT deficiency and in those with severe deficiency of uridine-diphospho-galactose-4-epimerase In summary, we have produced a mouse deficient in GALT activity which accumulates both galactose-(GAL-E), but not in those with galactokinase deficiency, in which the formation of gal-1-P is blocked 1-phosphate and galactose during the suckling period, but lacks the phenotype typically observed in by the enzyme deficiency. Clinically, patients with GALT deficiency and GAL-E deficiency both have GALT-deficient humans with similar biochemical parameters. Suckling mice do not demonstrate this liver and kidney toxicity, while patients with galactokinase (GALK) deficiency only develop cataracts phenotype despite consumption of large amounts of dietary galactose (16). Human infants consuming when exposed to dietary galactose (1) . These findings led to the very plausible explanation that accumulalactose-based formulas demonstrate clear symptoms. We conclude, therefore, that mice with absent tion of galactose and a side product, galactitol, result in the cataracts common to all three diseases, but GALT activity differ greatly in tolerance to dietary for its expression in embryonic stem cells. Proc Natl Acad galactose from humans with absent GALT activity, present an opportunity to study alternative path- mans may lead to enhanced therapy for patients with classical galactosemia.
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